Indivior Provides Full-Year 2026 Financial Guidance and Business Update

Core Viewpoint - Indivior PLC has announced its full-year 2026 financial guidance, indicating a strong growth trajectory for its SUBLOCADE product and overall financial performance [2][4]. Financial Guidance - Total net revenue is expected to be in the range of $1,125 million to $1,195 million [4][8]. - Total SUBLOCADE net revenue is projected to be between $905 million and $945 million [4][8]. - Non-GAAP operating expenses are anticipated to be in the range of $430 million to $450 million [4][8]. - Adjusted EBITDA is expected to be between $535 million and $575 million [4][8]. Business Strategy and Highlights - 2025 was identified as a transition year, with the completion of Phase I of the Indivior Action Agenda, focusing on generating momentum through revenue growth and organizational simplification [2][9]. - The company has entered Phase II of the Indivior Action Agenda, which aims to accelerate SUBLOCADE dispense unit growth and net revenue throughout 2026 [2][9]. - Indivior gained inclusion in the S&P SmallCap 600 index effective December 22, 2025 [9]. - The company received shareholder approval to change its domicile from the U.K. to the U.S., with the new U.S. parent company expected to be established by January 26, 2026 [9]. - Indivior has resolved a legacy U.S. Department of Justice matter by paying a total of $295 million [9]. Growth Projections - The company expects SUBLOCADE net revenue growth of 11% at the midpoint of its guidance range [2]. - Adjusted EBITDA is projected to grow by 35%, with an adjusted EBITDA margin increase of 14 percentage points [2].